Forschung + Publikationen

Wissenschaftliche
Schwerpunkte

✓ Grundlagenforschung über die Pathogenese & Therapie des Typ-2-Diabetes, des Metabolischen Syndroms und der Adipositas
✓ Migration und Diabetes mellitus
✓ Anwendung von telemedizinischen Technologien in der Dialektologie
✓ Klinische Forschung über die Behandlung von Adipositas, Diabetes und Lipidstoffwechselstörungen als Principal Investigator zahlreicher Studien und Klinischer Prüfungen in den Phasen 1, 2 und 3
✓ Ernährungsmedizin
✓ Originalarbeiten in zahlreichen Top-Journals, Übersichtsarbeiten, Buchbeiträge, zahlreiche Vorträge bei nationalen und internationalen Kongressen, Organisation von nationalen und internationalen Kongressen, Referent bei Fortbildungs-Veranstaltungen, Reviews in top Journalen (Diabetes, Diabetes Care, Diabetologia, European J. Clan. Investigation etc.)

Publikationen

Bücher:

  • Ludvik B (Ed): Risikofaktor Diabetes – Konzepte für ein Langzeitproblem. Uni-Med-Verlag Bremen, 1.Aufl. 2004 [ISBN: 3-89599-824-9]
  • Ludvik B, Toplak H: Medikamentöse Therapie der Adipositas. Springer Verlag Wien, 1.Aufl. 2006 [ISBN: 3-211-83815-5]
  • Mihaljevic K, Feffer S, Ludvik B: Essen mit Spass + Aktivsein mit Mass. So entkommen Sie dem Metabolischen Syndrom. Verlagshaus der Ärzte, 1.Aufl. 2006 [ISBN: 3-901488-75-8]
  • Pfeiffer A, Ludvik B, Kinzl J: Für immer dünn. Was Ärzte wirklich empfehlen. CD. Galila Hörbuchverlag. 1.Aufl. 2006 [ISBN: 3-902533-01-3]
  • Prager R, Abrahamian H, Kautzky-Willer A, Ludvik B, Schütz-Fuhrmann I, Weitgasser R: Diabetesmanagement mit Insulinanaloga. UNI-MED Verlag AG, 1. Auflage, 2008 [ISBN 978-3-89599-919-2]
  • Ludvik B, Fasching P, Lechleitner M, Prager R, Weitgasser R und Maierhofer W: Diabetes und seine Folgen verstehen – Gesundheitsratgeber. MedMedia Verlags- und Mediaservice GesmbH. 2. erweiterte Neuauflage 2011 [diabetes_guide_web.pdf 2,67 MB]

Buchbeiträge:

  • Weissel M, Punzengruber C, Hartter E, Burghuber OC, Ludvik B, Woloszczuk W: Effect of treatment with L-thyroxine on plansma ANP levels in athyreotic patients: indirect evidence for the necessity of adequate thyroid hormone levels to maintain normal ANP levels. In Advances in atrial peptide research. Vol 2 ed. Brenner BM, Saragh JH, Eds. 1988, p. 293-297
  • Graf H, Watzinger U, Ludvik B, Wagner A, Höcker B, Zweymuller KK: Eigenblutspende unter Erythropoietin – ein neues Konzept für elektive orthopädische Eingriffe. In 10 Jahre Zweymüller Hüftendoprothese. Zweymuller KK, Ed. 1990, p. 77-81
  • Kautzky-Willer A, Capek M, Pacini G, Ludvik B, Prager R: Insulin secretion, insulin sensitivity and hepatic insulin extraction in essential hypertension. In Current Topics in Diabetes Research. Karger Verlag, 1993, p. 250-253
  • Ludvik B: Adipositas – Diagnostik und Therapie. In Ernährungsmedizin. Widhalm K, Diallo-Ginstl E, Eds. ÖAK 2000, 334-346
  • Ludvik B: Konservative Therapie der morbiden Adipositas. In Morbide Adipositas – Klinik und Therapie. Hell E, Miller K, Eds. Ecomed 2000, 20-25
  • Ludvik B: Sekundäre Diabetesformen. In Diabetes in der Praxis. Waldhaeusl W, Gries FA, Scherbaum W, Eds. Springer Verlag Berlin 2004
  • Ludvik B: Diabetes mellitus: ein progerones Krankheitsbild. Therapie, Prävention und Einfluss von Lifestyle. In Angewandte Anti-Aging-Medizin. Gasser R (Hg). Verlagshaus der Ärzte 2004
  • Ludvik B, Bischof M, Kraupp M und Luger A: Diabetes mellitus und Lipidstoffwechsel. In Endokrinologie und Stoffwechsel – MCW Block 10. Facultas Verlags- und Buchhandels AG. 5. akt. Auflage 2011 [ISBN: 978-3-7089-0687-4]

Original- und Übersichts-Arbeiten:

  • Tobler, K., Freudenthaler, A., Baumgartner-Parzer, S.M., Wolzt, M., Ludvik, B., Nansalmaa, E., Nowotny, P.J., Seidinger, D., Steiner, S., Luger, A., Artwohl, M. Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int J Obes (Lond). 2010;34:687-700.
  • Schaller, G., Kretschmer, S., Gouya, G., Haider, D.G., Mittermayer, F., Riedl, M., Wagner, O., Pacini, G., Wolzt, M., Ludvik, B. Alcohol acutely increases vascular reactivity together with insulin sensitivity in
    type 2 diabetic men. Exp Clin Endocrinol Diabetes. 2010;118:57-60.
  • Maier, C., Riedl, M., Vila, G., Wolzt, M., Clodi, M., Ludvik, B., Luger, A. Differential regulation of plasma obestatin and ghrelin by meal intake and the cholinergic system in lean, but not obese individuals. J Clin Endocrinol Metab. 2010;95:E214-8.
  • Handisurya, A., Riedl, M., Vila, G., Maier, C., Clodi, M., Prikoszovich, T., Ludvik, B., Prager, G., Luger, A., Kautzky-Willer, A. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg. 2010;20:198-203.
  • Bohdjalian, A., Langer, F.B., Shakeri-Leidenmuhler, S., Gfrerer, L., Ludvik, B., Zacherl, J., Prager, G. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20:535-40.
  • Vila, G., Riedl, M., Maier, C., Struck, J., Morgenthaler, N.G., Handisurya, A., Prager, G., Ludvik, B., Clodi, M., Luger, A. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity (Silver Spring). 2009;17:1184-8.
  • Shakeri-Manesch, S., Zeyda, M., Huber, J., Ludvik, B., Prager, G., Stulnig, T.M. Diminished upregulation
    of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance. Int J Obes (Lond). 2009;33:1257-64.
  • Schindler, K., Rieger, A., Tura, A., Gmeinhardt, B., Touzeau-Romer, V., Haider, D., Pacini, G., Ludvik, B.  The Effect of Rosiglitazone on Insulin Sensitivity, Beta Cell Function, Bone Mineral Density, and Body Composition in HIV-positive Patients on Highly-active Antiretroviral Therapy (HAART). Horm Metab Res. 2009;41:573-9.
  • Ludvik, B., Brath, H., Wascher, T., Toplak, H. [The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus]. Wien Klin Wochenschr. 2009;121:473-82.
  • Bohdjalian, A., Prager, G., Rosak, C., Weiner, R., Jung, R., Schramm, M., Aviv, R., Schindler, K., Haddad, W., Rosenthal, N., Ludvik, B. Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation. Obes Surg. 2009;19:1221-7.
  • Bohdjalian, A., Ludvik, B., Guerci, B., Bresler, L., Renard, E., Nocca, D., Karnieli, E., Assalia, A., Prager, R., Prager, G. Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes. Surg Endosc. 2009;23:1955-60.
  • Riedl, M., Vila, G., Maier, C., Handisurya, A., Shakeri-Manesch, S., Prager, G., Wagner, O., Kautzky-Willer, A., Ludvik, B., Clodi, M., Luger, A. Plasma osteopontin increases after bariatric surgery and correlates
    with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab. 2008;93:2307-12.
  • Morak, J., Schindler, K., Goerzer, E., Kastner, P., Toplak, H., Ludvik, B., Schreier, G. A pilot study of mobile phone-based therapy for obese patients. J Telemed Telecare. 2008;14:147-9.
  • Maier, C., Riedl, M., Vila, G., Nowotny, P., Wolzt, M., Clodi, M., Ludvik, B., Luger, A. Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity. Diabetes. 2008;57:2332-40.
  • Ludvik, B., Hanefeld, M., Pacini, G. Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects. Diabetes Obes Metab. 2008;10:586-92.
  • Langer, F.B., Bohdjalian, A., Shakeri-Manesch, S., Felberbauer, F.X., Ludvik, B., Zacherl, J., Prager, G. Inadequate weight loss vs secondary weight regain: laparoscopic conversion from gastric banding to Roux-en-Y gastric bypass. Obes Surg. 2008;18:1381-6.
  • Kiefer, F.W., Zeyda, M., Todoric, J., Huber, J., Geyeregger, R., Weichhart, T., Aszmann, O., Ludvik, B., Silberhumer, G.R., Prager, G., Stulnig, T.M. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology. 2008;149:1350-7.
  • Huber, J., Kiefer, F.W., Zeyda, M., Ludvik, B., Silberhumer, G.R., Prager, G., Zlabinger, G.J., Stulnig, T.M. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab. 2008;93:3215-21.
  • Brema, I., Hatunic, M., Finucane, F., Burns, N., Nolan, J.J., Haider, D., Wolzt, M., Ludvik, B. Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:600-2.
  • Vila, G., Maier, C., Riedl, M., Nowotny, P., Ludvik, B., Luger, A., Clodi, M. Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab. 2007;92:3930-4.
  • Tripp, B., Ludvik, B. [Antihypertensive and metabolic effects of telmisartan in patients with the metabolic syndrome in primary care–a field study]. Wien Med Wochenschr. 2007;157:223-7.
  • Kollmann, A., Riedl, M., Kastner, P., Schreier, G., Ludvik, B. Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients. J Med Internet Res. 2007;9:e36.
  • Haider, D.G., Schindler, K., Prager, G., Bohdjalian, A., Luger, A., Wolzt, M., Ludvik, B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2007;92:1168-71.
  • Haider, D.G., Schindler, K., Mittermayer, F., Muller, M., Nowotny, P., Rieger, A., Luger, A., Ludvik, B., Wolzt, M. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients. Clin Pharmacol Ther. 2007;81:580-5.
  • Haider, D.G., Schindler, K., Bohdjalian, A., Prager, G., Luger, A., Wolzt, M., Ludvik, B. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab. 2007;9:761-3.
  • Dorner, T., Fodor, J.G., Lawrence, K., Ludvik, B., Rieder, A. HDL-knowledge in the lay public: results of a representative population survey. Atherosclerosis. 2007;195:195-8.
  • Anderwald, C., Anderwald-Stadler, M., Promintzer, M., Prager, G., Mandl, M., Nowotny, P., Bischof, M.G., Wolzt, M., Ludvik, B., Kastenbauer, T., Pacini, G., Luger, A., Krebs, M. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care. 2007;30:2374-80.
  • Schindler, K., Haider, D., Wolzt, M., Rieger, A., Gmeinhart, B., Luger, A., Nowotny, P., Ludvik, B. Impact
    of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects. Eur J Clin Invest. 2006;36:640-6.
  • Riener, R., Schindler, K., Ludvik, B. Psychosocial variables, eating behavior, depression, and binge eating in morbidly obese subjects. Eat Behav. 2006;7:309-14.
  • Langer, F.B., Bohdjalian, A., Felberbauer, F.X., Fleischmann, E., Reza Hoda, M.A., Ludvik, B., Zacherl, J., Jakesz, R., Prager, G. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg. 2006;16:166-71.
  • Kautzky-Willer, A., Tura, A., Winzer, C., Wagner, O.F., Ludvik, B., Hanusch-Enserer, U., Prager, R., Pacini, G. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione. Diabetes Obes Metab. 2006;8:561-7.
  • Haider, D.G., Schindler, K., Schaller, G., Prager, G., Wolzt, M., Ludvik, B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006;91:1578-81.
  • Bohdjalian, A., Prager, G., Aviv, R., Policker, S., Schindler, K., Kretschmer, S., Riener, R., Zacherl, J., Ludvik, B. One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg. 2006;16:627-34.
  • Langer, F.B., Reza Hoda, M.A., Bohdjalian, A., Felberbauer, F.X., Zacherl, J., Wenzl, E., Schindler, K., Luger, A., Ludvik, B., Prager, G. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024-9.
  • Cauza, E., Hanusch-Enserer, U., Strasser, B., Ludvik, B., Metz-Schimmerl, S., Pacini, G., Wagner, O., Georg, P., Prager, R., Kostner, K., Dunky, A., Haber, P. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehabil. 2005;86:1527-33.
  • Cauza, E., Hanusch-Enserer, U., Strasser, B., Ludvik, B., Kostner, K., Dunky, A., Haber, P. Continuous glucose monitoring in diabetic long distance runners. Int J Sports Med. 2005;26:774-80.
  • Abrahamian, H., Ludvik, B., Schernthaner, G., Prager, R., Zellenka, U., Knudsen, L., Wascher, T. Improvement of glucose tolerance in type 2 diabetic patients: traditional vs. modern insulin regimens (results from the Austrian Biaspart Study). Horm Metab Res. 2005;37:684-9.
  • Tripp, B., Ludvik, B. [Pharmacotherapy of obesity]. Wien Med Wochenschr. 2004;154:320-8.
  • Tripp, B., Ludvik, B. [Novel anti-obesity drugs]. Acta Med Austriaca. 2004;31:133-8.
  • Schindler, K., Prager, G., Ballaban, T., Kretschmer, S., Riener, R., Buranyi, B., Maier, C., Luger, A., Ludvik, B. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest. 2004;34:549-54.
  • Schindler, K., Ludvik, B. [Assessment of body composition–methods and practical aspects]. Wien Med Wochenschr. 2004;154:305-12.
  • Ludvik, B., Neuffer, B., Pacini, G. Efficacy of Ipomoea batatas (Caiapo) on diabetes control in type 2 diabetic subjects treated with diet. Diabetes Care. 2004;27:436-40.
  • Ludvik, B. [Obesity]. Wien Med Wochenschr. 2004;154:295.
  • Bohdjalian, A., Langer, F., Reza Hoda, M.A., Felberbauer, F., Silberhumer, G., Zacherl, J., Schindler, K., Luger, A., Ludvik, B., Prager, G. [Surgical treatment of obesity]. Wien Med Wochenschr. 2004;154:329-33.
  • Tura, A., Pacini, G., Kautzky-Willer, A., Ludvik, B., Prager, R., Thomaseth, K. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. Am J Physiol Endocrinol Metab. 2003;285:E155-62.
  • Ludvik, B., Waldhausl, W., Prager, R., Kautzky-Willer, A., Pacini, G. Mode of action of ipomoea batatas (Caiapo) in type 2 diabetic patients. Metabolism. 2003;52:875-80.
  • Ludvik, B., Thomaseth, K., Nolan, J.J., Clodi, M., Prager, R., Pacini, G. Inverse relation between amylin
    and glucagon secretion in healthy and diabetic human subjects. Eur J Clin Invest. 2003;33:316-22.
  • Ludvik, B.H., Mahdjoobian, K., Waldhaeusl, W., Hofer, A., Prager, R., Kautzky-Willer, A., Pacini, G. The effect of Ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study. Diabetes Care. 2002;25:239-40.
  • Georg, P., Kautzky-Willer, A., Mahdjoobian, K., Hofer, A., Prager, R., Pacini, G., Ludvik, B.H. Influence of metabolic control on splanchnic glucose uptake, insulin sensitivity, and the time required for glucose absorption in patients with type 1 diabetes. Diabetes Care. 2002;25:2042-7.
  • Tura, A., Ludvik, B., Nolan, J.J., Pacini, G., Thomaseth, K. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001;281:E966-74.
  • Mari, A., Pacini, G., Murphy, E., Ludvik, B., Nolan, J.J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24:539-48.
  • Kautzky-Willer, A., Pacini, G., Tura, A., Bieglmayer, C., Schneider, B., Ludvik, B., Prager, R., Waldhausl, W. Increased plasma leptin in gestational diabetes. Diabetologia. 2001;44:164-72.
  • Georg, P., Ludvik, B. Metabolic changes in the ageing man. Wien Med Wochenschr. 2001;151:451-6.
  • Riedl, M., Ludvik, B., Pacini, G., Clodi, M., Kotzmann, H., Wagner, O., Kautzky-Willer, A., Prager, R., Luger, A. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy. Eur J Clin Invest. 2000;30:771-8.
  • Ludvik, B. [Diabetes therapy related to etiology. Indications, uses and side effects of new insulin sensitizers]. MMW Fortschr Med. 2000;142:27-8.
  • Ludvik, B. [Weight loss by increasing energy consumption and thermogenesis]. Acta Med Austriaca. 1998;25:136-7.
  • Clodi, M., Thomaseth, K., Pacini, G., Hermann, K., Kautzky-Willer, A., Waldhusl, W., Prager, R., Ludvik, B.Distribution and kinetics of amylin in humans. Am J Physiol. 1998;274:E903-8.
  • Thomaseth, K., Pacini, G., Clodi, M., Kautzky-Willer, A., Nolan, J.J., Prager, R., Olefsky, J.M., Ludvik, B.Amylin release during oral glucose tolerance test. Diabet Med. 1997;14 Suppl 2:S29-34.
  • Nolan, J.J., Ludvik, B., Baloga, J., Reichart, D., Olefsky, J.M. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM. Diabetes. 1997;46:994–1OOO.
  • Ludvik, B., Nolan, J.J., Roberts, A., Baloga, J., Joyce, M., Bell, J.M., Olefsky, J.M. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest. 1997;100:2354-61.
  • Ludvik, B., Kautzky-Willer, A., Prager, R., Thomaseth, K., Pacini, G. Amylin: history and overview. Diabet Med. 1997;14 Suppl 2:S9-13.
  • Ludvik, B. [Amylin/IAPP (islet amyloid polypeptide)–physiology and clinical significance]. Wien Klin Wochenschr. 1997;109:379-83.
  • Kautzky-Willer, A., Thomaseth, K., Ludvik, B., Nowotny, P., Rabensteiner, D., Waldhausl, W., Pacini, G., Prager, R. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes. 1997;46:607-14.
  • Kautzky-Willer, A., Prager, R., Waldhausl, W., Pacini, G., Thomaseth, K., Wagner, O.F., Ulm, M., Streli, C., Ludvik, B. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care. 1997;20:1717-23.
  • Thomaseth, K., Kautzky-Willer, A., Ludvik, B., Prager, R., Pacini, G. Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am J Physiol. 1996;270:E522-31.
  • Kautzky-Willer, A., Thomaseth, K., Clodi, M., Ludvik, B., Waldhausl, W., Prager, R., Pacini, G. Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism. 1996;45:486-91.
  • Ludvik, B., Nolan, J.J., Roberts, A., Baloga, J., Joyce, M., Bell, J.M., Olefsky, J.M. A noninvasive method
    to measure splanchnic glucose uptake after oral glucose administration. J Clin Invest. 1995;95:2232-8.
  • Ludvik, B., Nolan, J.J., Baloga, J., Sacks, D., Olefsky, J. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes. 1995;44:1121-5.
  • Kotzmann, H., Linkesch, M., Ludvik, B., Clodi, M., Luger, A., Schernthaner, G., Prager, R., Klauser, R. Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover. Eur J Clin Invest. 1995;25:942-7.
  • Kautzky-Willer, A., Pacini, G., Barnas, U., Ludvik, B., Streli, C., Graf, H., Prager, R. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int. 1995;47:200-6.
  • Nolan, J.J., Ludvik, B., Beerdsen, P., Joyce, M., Olefsky, J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994;331:1188-93.
  • Ludvik, B., Clodi, M., Kautzky-Willer, A., Schuller, M., Graf, H., Hartter, E., Pacini, G., Prager, R. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion. J Clin Invest. 1994;94:2045-50.
  • Kautzky-Willer, A., Thomaseth, K., Pacini, G., Clodi, M., Ludvik, B., Streli, C., Waldhausl, W., Prager, R. Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia. 1994;37:188-94.
  • Capek, M., Schnack, C., Ludvik, B., Kautzky-Willer, A., Banyai, M., Prager, R. Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study. Clin Investig. 1994;72:961-6.
  • Ludvik, B., Mayer, G., Stifter, S., Putz, D., Barnas, U., Graf, H. Effects of dichloroacetate on exercise performance in healthy volunteers. Pflugers Arch. 1993;423:251-4.
  • Ludvik, B., Clodi, M., Kautzky-Willer, A., Capek, M., Hartter, E., Pacini, G., Prager, R. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia. 1993;36:84-7.
  • Kautzky-Willer, A., Pacini, G., Weissel, M., Capek, M., Ludvik, B., Prager, R. Elevated hepatic insulin extraction in essential hypertension. Hypertension. 1993;21:646-53.
  • Kautzky-Willer, A., Pacini, G., Ludvik, B., Schernthaner, G., Prager, R. Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism. 1992;41:1304-12.
  • Prager, R., Ludvik, B., Hartter, E. [Role of amylin in the pathogenesis of type II diabetes mellitus]. Acta Med Austriaca. 1991;18:61-2.
  • Ludvik, B., Peer, G., Berzlanovich, A., Stifter, S., Graf, H. Effects of dichloroacetate and bicarbonate on haemodynamic parameters in healthy volunteers. Clin Sci (Lond). 1991;80:47-51.
  • Ludvik, B., Lell, B., Hartter, E., Schnack, C., Prager, R. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes. Diabetes. 1991;40:1615-9.
  • Ludvik, B., Kueenburg, E., Brunnbauer, M., Schernthaner, G., Prager, R. The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension. J Cardiovasc Pharmacol. 1991;18 Suppl 2:S157-9.
  • Hartter, E., Svoboda, T., Ludvik, B., Schuller, M., Lell, B., Kuenburg, E., Brunnbauer, M., Woloszczuk, W., Prager, R. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia. 1991;34:52-4.
  • Hartter, E., Svoboda, T., Lell, B., Schuller, M., Ludvik, B., Woloszczuk, W., Prager, R. Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus. Lancet. 1990;335:854.
  • Graf, H., Watzinger, U., Ludvik, B., Wagner, A., Hocker, P., Zweymuller, K.K. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. BMJ. 1990;300:1627-8.
  • Ludvik, B., Scheithauer, W., Wrba, F., Schratter, M., Schiessel, R., Schernthaner, G. [Gestagen receptor-positive, solid-cystic acinar-cell tumor of the pancreas]. Dtsch Med Wochenschr. 1989;114:903-6.
  • Wrba, F., Chott, A., Schratter, M., Ludvik, B., Krisch, K., Holzner, J.H. [Fine-needle puncture cytology of a solid cystic tumor of the pancreas]. Pathologe. 1988;9:340-4.
  • Wrba, F., Chott, A., Ludvik, B., Schratter, M., Spona, J., Reiner, A., Schernthaner, G., Krisch, K. Solid
    and cystic tumour of the pancreas; a hormonal-dependent neoplasm? Histopathology. 1988;12:338-40.
  • Ludvik, B., Niederle, B., Roka, R., Schernthaner, G., Neuhold, N. [Malignant aldosteronoma in the differential diagnosis of Conn syndrome]. Acta Med Austriaca. 1988;15:117-20.
  • Hay, U., Ludvik, B., Gisinger, C., Schernthaner, G. [Lack of effect of ACE inhibition on severe proteinuria
    in diabetic nephropathy–a 6-month-long study]. Schweiz Med Wochenschr. 1988;118:165-9.
  • Punzengruber, C., Hartter, E., Weissel, M., Burghuber, O.C., Ludvik, B., Woloszczuk, W. [Peripheral and right atrial plasma levels of atrial natriuretic peptide and their relation to mean atrial pressure]. Z Kardiol. 1987;76:72-5.
  • Weissel, M., Punzengruber, C., Hartter, E., Ludvik, B., Woloszczuk, W. Thyroid hormones and pericardial effusion may influence plasma levels of atrial natriuretic peptide (ANP) in humans. Klin Wochenschr. 1986;64 Suppl 6:93-6.
  • Hartter, E., Weissel, M., Stummvoll, H.K., Woloszczuk, W., Punzengruber, C., Ludvik, B. Atrial natriuretic peptide concentrations in blood from right atrium in patient with severe right heart failure. Lancet. 1985;2:93-4.